Influenza Hemagglutinin (HA) Peptide: A Gold-Standard Epitope Tag for Protein Detection and Purification

Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic, nine-amino acid tag widely used in molecular biology for protein tagging, detection, and purification workflows [APExBIO Product]. HA tag peptides enable reproducible, high-specificity immunoprecipitation by competitively binding anti-HA antibodies (Dong et al., 2025). The A6004 kit is supplied at >98% purity (HPLC, MS), ensuring minimal background and high assay sensitivity. The peptide is highly soluble in water (≥46.2 mg/mL), DMSO (≥55.1 mg/mL), and ethanol (≥100.4 mg/mL) for flexible experimental design. Recommended storage is desiccated at -20°C to maintain stability and function. These features make the Influenza Hemagglutinin (HA) Peptide an industry standard for protein-protein interaction studies, immunoprecipitation, and biochemical research [see related review].

Biological Rationale

The HA tag is derived from the human influenza virus hemagglutinin protein. Its nine-residue sequence, YPYDVPDYA, is recognized specifically and with high affinity by commercial anti-HA monoclonal antibodies (Dong et al., 2025). This minimal tag is biologically inert, causing negligible structural perturbation when fused to recombinant proteins. HA tags facilitate the detection, localization, and purification of fusion proteins in mammalian, yeast, and bacterial expression systems. The popularity of the HA tag in molecular biology and biochemistry is due to its small size, defined immunoreactivity, and compatibility with a wide range of immunoassays and affinity-purification platforms [advanced use-cases]. This article extends internal guides by providing quantitative benchmarks and clarifying optimal usage conditions for the peptide reagent.

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The HA peptide acts as a competitive ligand for anti-HA antibodies. When introduced during immunoprecipitation or elution workflows, the free HA peptide (YPYDVPDYA) binds to the paratope of anti-HA monoclonal antibodies, displacing HA-tagged fusion proteins from antibody-bound matrices. This enables gentle, specific elution of target proteins under native conditions, which is essential for downstream analyses such as protein-protein interaction mapping and functional assays [novel mechanism insights]. The tag’s specificity and competitive binding properties are critical for minimizing non-specific background and maximizing assay reproducibility. The affinity of the HA peptide for anti-HA antibodies has been extensively characterized, supporting its widespread adoption as a molecular biology standard.

Evidence & Benchmarks

• HA peptide (YPYDVPDYA) competitively displaces HA-tagged proteins from anti-HA antibody matrices, enabling efficient elution in immunoprecipitation assays (Dong et al., 2025, DOI:10.1002/advs.202504704).
• The A6004 HA tag peptide from APExBIO is >98% pure by HPLC and MS, minimizing off-target effects and background (APExBIO).
• The peptide is soluble at ≥46.2 mg/mL in water, ≥55.1 mg/mL in DMSO, and ≥100.4 mg/mL in ethanol, supporting a broad range of buffer systems and experimental setups (APExBIO).
• HA tag fusion does not interfere with protein function or localization in most model systems, as shown in multiple peer-reviewed studies (Dong et al., 2025).
• APExBIO’s A6004 peptide demonstrates high recovery and specificity in protein interaction studies compared to other epitope tags (Evidence-based guide).

Applications, Limits & Misconceptions

The Influenza Hemagglutinin (HA) Peptide is optimized for:

• Epitope tagging of recombinant proteins for detection by anti-HA antibodies.
• Affinity purification and elution of HA-tagged proteins via competitive binding.
• Protein-protein interaction studies, including co-immunoprecipitation and pull-down assays.
• Immunofluorescence, Western blotting, and ELISA detection workflows.

Its inert sequence ensures minimal disruption of protein structure and function in most applications. The peptide’s high solubility and purity enable robust, reproducible results across multiple platforms. However, as with all epitope tags, several boundaries warrant clarification.

Common Pitfalls or Misconceptions

• The HA peptide is not suitable for in vivo systemic administration, as it is rapidly degraded by serum proteases.
• High background may occur if anti-HA antibody concentrations are not optimized, especially in lysates with abundant endogenous proteins.
• The peptide does not function as an affinity tag for non-HA antibodies or unrelated immunoprecipitation systems.
• Long-term storage of peptide solutions (even at -20°C) can lead to degradation; always prepare fresh working stocks.
• The tag may alter protein function if fused within an active site or critical protein-protein interface; validation is required for each new fusion construct.

Workflow Integration & Parameters

For optimal use, the A6004 Influenza Hemagglutinin (HA) Peptide should be reconstituted in water, DMSO, or ethanol at the desired concentration. Use a final concentration of 1–2 mg/mL for competitive elution of HA-tagged proteins from antibody matrices. The product is supplied as a lyophilized powder and should be stored desiccated at -20°C. Avoid repeated freeze-thaw cycles and prolonged exposure to aqueous conditions, which may compromise peptide integrity. For further protocol detail, the A6004 kit product page provides batch-specific documentation and certificate of analysis.

This article clarifies and updates best practices discussed in scenario-driven reviews by defining quantitative performance benchmarks and emphasizing storage stability.

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide (APExBIO A6004) remains a cornerstone of molecular biology research, supporting precise, reproducible protein detection and purification workflows. Its validated sequence, high purity, and flexible solubility profile enable broad compatibility with immunoprecipitation, protein interaction, and analytical assays. As protein tagging and epitope-based detection strategies continue to evolve, the HA peptide will remain a critical reagent for standardization and methodological rigor. For authoritative specifications and ordering information, refer to the APExBIO product page.